Bilirubin, a yellowish pigment produced during the breakdown of red blood cells, serves as a vital marker of liver function and blood health. Within the bloodstream, bilirubin exists in two main forms: indirect (unconjugated) and direct (conjugated) bilirubin.
Direct bilirubin, a water-soluble form, is a key component of liver function tests and serves as a crucial indicator of liver and biliary tract health. Elevated levels of direct bilirubin can signify liver disease, bile duct obstruction, or other hepatobiliary disorders.
Understanding the clinical significance of direct bilirubin as a blood test is essential for diagnosing and managing various medical conditions related to liver function and biliary tract integrity.
Bilirubin is a yellowish pigment produced by the breakdown of heme, a component of hemoglobin found in red blood cells. After red blood cells complete their lifespan and are broken down, bilirubin is released and transported to the liver.
In the liver, bilirubin is conjugated with glucuronic acid through a process called conjugation, which renders it water-soluble and allows it to be excreted into bile. From there, bilirubin travels through the biliary tract to the intestines, where it undergoes further metabolism by gut bacteria and is ultimately eliminated from the body through feces. When the liver cannot process bilirubin quickly enough, it begins to build up in the body and is eliminated via the urine.
Because bilirubin is primarily made in the liver as a byproduct of red blood cell breakdown and serves as an important marker of liver function and overall blood health.
Direct bilirubin, also known as conjugated bilirubin, is the water-soluble form of bilirubin that has undergone conjugation in the liver. Direct bilirubin represents the fraction of bilirubin that has been processed and excreted by the liver, providing insights into the liver's ability to metabolize and eliminate waste products.
Direct bilirubin serves as an important marker of liver function and biliary tract integrity. Once formed in the liver, direct bilirubin is excreted into bile and ultimately eliminated from the body in stool.
Elevated levels of direct bilirubin in the bloodstream can indicate hepatobiliary dysfunction such as liver disease, bile duct obstruction, or impaired bilirubin conjugation. Therefore, measuring direct bilirubin levels through blood tests is crucial for diagnosing and monitoring various liver and biliary tract disorders.
Total bilirubin represents the combined levels of both indirect (unconjugated) and direct (conjugated) bilirubin in the bloodstream. While total bilirubin provides an overall measure of bilirubin concentration, direct bilirubin specifically reflects the fraction of bilirubin that has undergone conjugation in the liver.
By differentiating between direct and indirect bilirubin levels, clinicians can gain valuable insights into the underlying etiology of elevated bilirubin levels.
Elevated direct bilirubin levels suggest hepatobiliary dysfunction, while elevated indirect bilirubin levels may indicate increased hemolysis or impaired hepatic uptake. Therefore, understanding the distinction between direct and total bilirubin levels is essential for accurate diagnosis and appropriate management of liver and biliary tract disorders.
The direct bilirubin test may be done through blood or urine.
A blood test typically requires a blood sample obtained through venipuncture, where a healthcare professional collects blood from a vein in the arm using a sterile needle and syringe or a vacuum tube system.
During a urine test for bilirubin, a urine sample is collected and analyzed using a dipstick or laboratory equipment to detect the presence of bilirubin. The test involves dipping a specially treated strip into the urine sample which reacts with bilirubin, causing a color change that indicates its presence in the urine, aiding in the diagnosis of liver or biliary tract disorders.
Fasting is not generally required, although your healthcare provider may request fasting especially if this test is ordered in conjunction with other tests.
Reference ranges for bilirubin may differ based on a person’s age, and they also may differ between labs.
Serum values of direct bilirubin for an adult, elderly person, or child: 0.1-0.3 mg/dL or 1.7-5.1 μmol/L (SI units)
Serum values of total bilirubin for a newborn: 1.0-12.0 mg/dL or 17.1-205 μmol/L (SI units)
The reference range for direct bilirubin in blood typically falls between 0.1 to 0.3 mg/dL (1.7 to 5.1 μmol/L).
In urine, the presence of bilirubin is considered abnormal, and its detection may suggest liver or biliary tract dysfunction, regardless of specific quantitative reference ranges.
Elevated levels of direct bilirubin in the bloodstream or urine may indicate hepatobiliary dysfunction and liver disease. Direct bilirubin is primarily excreted into bile by the liver, and increased levels in blood and/or urine suggest impairment in bilirubin metabolism, conjugation, or excretion.
Consequently, elevated direct bilirubin levels are often associated with conditions such as cholestasis, bile duct obstruction, hepatitis, cirrhosis, or other hepatobiliary disorders, necessitating further evaluation and management.
Cholestasis: Intrahepatic or extrahepatic obstruction of bile flow.
Bile duct obstruction: Gallstones, tumors, strictures, or inflammation obstructing the bile ducts.
Hepatitis: Inflammation of the liver due to viral infections, autoimmune diseases, or hepatotoxic drugs.
Cirrhosis: Chronic liver damage leading to fibrosis and impaired liver function.
Congenital disorders: Dubin-Johnson syndrome, Rotor syndrome, or genetic defects affecting bilirubin metabolism.
Medications: Drug-induced liver injury or adverse reactions affecting bilirubin metabolism.
Pancreatic disorders: Pancreatic cancer or pancreatitis causing bile duct obstruction.
Hemolytic disorders: Increased red blood cell breakdown leading to elevated bilirubin levels.
Biliary atresia: Congenital absence or obstruction of bile ducts in infants.
Alcoholic liver disease: Liver damage caused by chronic alcohol consumption.
Primary biliary cholangitis: Autoimmune destruction of bile ducts leading to cholestasis.
Primary sclerosing cholangitis: Chronic inflammation and scarring of bile ducts causing obstruction.
Drug-induced liver injury: Medications or toxins damaging liver cells and impairing bilirubin metabolism.
These conditions require thorough evaluation, including medical history, physical examination, laboratory tests, imaging studies, and liver biopsy if necessary, to accurately diagnose and manage elevated direct bilirubin levels and associated hepatobiliary disorders.
Neonatal Jaundice: Etiology and Pathophysiology
Neonatal jaundice, characterized by yellowing of the skin and eyes in newborn infants, occurs due to the accumulation of bilirubin in the bloodstream. In newborns, jaundice commonly occurs within the first few days of life due to physiological immaturity of the liver, resulting in decreased bilirubin conjugation and clearance.
Under normal circumstances, bilirubin is primarily metabolized and excreted by the liver, but in newborns, immature hepatic enzyme systems may lead to inadequate bilirubin processing, causing its accumulation in the bloodstream.
This excess bilirubin can cross the blood-brain barrier and cause neurotoxicity, leading to kernicterus, a severe neurological condition if left untreated.
Factors Contributing to Elevated Direct Bilirubin Levels in Newborns
Several factors contribute to elevated direct bilirubin levels in newborns, leading to neonatal jaundice. These factors include physiological jaundice, which is a common and benign condition resulting from the immature liver function and increased red blood cell breakdown in newborns.
Additionally, breastfeeding jaundice may occur due to inadequate milk intake, leading to dehydration and decreased bilirubin excretion. Furthermore, breast milk jaundice can arise from substances in breast milk that inhibit bilirubin conjugation in the liver.
In some cases, pathological causes such as hemolytic disease of the newborn, ABO or Rh incompatibility, or genetic disorders affecting bilirubin metabolism may contribute to elevated direct bilirubin levels and require prompt evaluation and management by healthcare professionals.
Understanding the cause for elevated direct bilirubin is essential. Under the guidance of a medical professional, an individual may then be guided to use natural support for elevated direct bilirubin, including:
[1.] Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi SM, Rahimi R, Abdollahi M. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients. 2018 Jul 1;10(7):855. doi: 10.3390/nu10070855. PMID: 29966389; PMCID: PMC6073929.
[2.] Gao R, Tao Y, Zhou C, Li J, Wang X, Chen L, Li F, Guo L. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019 Feb;54(2):169-177. doi: 10.1080/00365521.2019.1568544. Epub 2019 Mar 7. PMID: 30843436.
[3.] Ghaffari AR, Noshad H, Ostadi A, Ghojazadeh M, Asadi P. The effects of milk thistle on hepatic fibrosis due to methotrexate in rat. Hepat Mon. 2011 Jun;11(6):464-8. PMID: 22087179; PMCID: PMC3212785.
[4.] Hoilat GJ, John S. Bilirubinuria. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557439/
[5.] Mahboubi, Mohaddese; Mahboubi, Mona. Hepatoprotection by dandelion (Taraxacum officinale) and mechanisms. Asian Pacific Journal of Tropical Biomedicine 10(1):p 1-10, January 2020. | DOI: 10.4103/2221-1691.273081
[6.] Wehbi M. Bilirubin: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online March 4, 2020. https://emedicine.medscape.com/article/2074068-overview
[7.] Žiberna L, Jenko-Pražnikar Z, Petelin A. Serum Bilirubin Levels in Overweight and Obese Individuals: The Importance of Anti-Inflammatory and Antioxidant Responses. Antioxidants (Basel). 2021 Aug 26;10(9):1352. doi: 10.3390/antiox10091352. PMID: 34572984; PMCID: PMC8472302.